Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X1YZ
|
|||
| Former ID |
DIB001064
|
|||
| Drug Name |
KM-4056
|
|||
| Synonyms |
Anti-LGR5 monoclonal antibody (cancer), Kyowa Hakko Kirin
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Kyowa Hakko Kirin Co Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Leucine-rich repeat-containing GPCR 5 (LGR5) | Target Info | . | [1] |
| Reactome | Regulation of FZD by ubiquitination | |||
| WikiPathways | Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 148). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.